Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/232.5
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Plural morpholine rings attached directly or indirectly to each other by nonionic bonding > Additional hetero ring attached directly or indirectly to the morpholines by nonionic bonding > Polycyclo ring system having the additional hetero ring as one of the cyclos
Description: Subject matter in which the additional hetero ring is one of the cyclos of a polycyclo ring system.










Patents under this class:
1 2 3 4 5 6

Patent Number Title Of Patent Date Issued
8680095 Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs Mar. 25, 2014
8664218 Pharmaceutical compounds Mar. 4, 2014
8658640 JNK inhibitors for the treatment of endometriosis Feb. 25, 2014
8592414 JNK inhibitors for the treatment of endometriosis Nov. 26, 2013
8586580 2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors Nov. 19, 2013
8563540 Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use Oct. 22, 2013
8557807 Thienopyranones as kinase inhibitors Oct. 15, 2013
8455252 Materials and methods for sensitizing multidrug resistant cells Jun. 4, 2013
8445487 Purine PI3K inhibitor compounds and methods of use May. 21, 2013
8440651 Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use May. 14, 2013
8435985 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors May. 7, 2013
8389516 Antibacterial compositions Mar. 5, 2013
8383619 Pharmaceutical compounds Feb. 26, 2013
8354400 Benzoxazole compounds and methods of use Jan. 15, 2013
8349845 Thiazolopyrimidines for use in therapy Jan. 8, 2013
8343957 Therapeutic pyrazoloquinoline urea derivatives Jan. 1, 2013
RE43878 Amidophenoxyindazoles useful as inhibitors of c-Met Dec. 25, 2012
8338414 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient Dec. 25, 2012
8314098 Pyrazolo-pyrimidine compounds Nov. 20, 2012
8263584 Imidazopyridines Sep. 11, 2012
8198316 Process for the preparation of 5,6 -dihydro -4H-4(S)-ethylamino-6(S)-methylthieno[2,3-b] thiopyran-2-sulfonamide- 7,7 -dioxide and its salt Jun. 12, 2012
8193164 Organic compounds Jun. 5, 2012
8173648 1,2,3,4-tetrahydroisoquinoline derivatives, preparation process therefor and pharmaceutical composition containing the same May. 8, 2012
8101602 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors Jan. 24, 2012
8030302 Amidophenoxyindazoles useful as inhibitors of c-Met Oct. 4, 2011
7973030 Benzothiazepine and benzothiepine compounds Jul. 5, 2011
7951801 Beta-carbolines useful for treating inflammatory disease May. 31, 2011
7951802 Use of 7-azaindoles in the inhibition of c-Jun N-terminal kinase May. 31, 2011
7902189 Compounds Mar. 8, 2011
7855199 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient Dec. 21, 2010
7776854 Benzazole derivatives for the treatment of scleroderma Aug. 17, 2010
7727985 Beta-carbolines useful for treating inflammatory disease Jun. 1, 2010
7718653 Pyrimidine derivatives for inhibiting Eph receptors May. 18, 2010
7696203 DNA-PK inhibitors Apr. 13, 2010
7678792 Compositions and methods for modulating c-kit and PDGFR receptors Mar. 16, 2010
7622497 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis Nov. 24, 2009
7576079 Viral polymerase inhibitors Aug. 18, 2009
7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors Jan. 27, 2009
7417066 Inhibitors of soluble adenylate cyclase Aug. 26, 2008
7414073 Cytotoxic agents containing novel potent taxanes and their therapeutic use Aug. 19, 2008
7410990 Heterocyclic compounds Aug. 12, 2008
7405211 Therapeutic morpholino-substituted compounds Jul. 29, 2008
7396828 PI-3 kinase inhibitor prodrugs Jul. 8, 2008
7378421 Chromenone derivatives May. 27, 2008
7358247 Mycophenolate mofetil impurity Apr. 15, 2008
7300930 Therapeutic acridone and acridine compounds Nov. 27, 2007
7268143 Isoquinoline derivatives and methods of use thereof Sep. 11, 2007
7265103 Substituted amino isoxazoline derivatives and their use as anti-depressants Sep. 4, 2007
7253165 Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D.sub.4 antagonists Aug. 7, 2007
7144890 Spiro-pentacyclic compounds Dec. 5, 2006

1 2 3 4 5 6










 
 
  Recently Added Patents
White light emitting lamp and white LED lighting apparatus including the same
Estimating optical characteristics of a camera component using sharpness sweep data
Implicit certificate scheme
Circuit arrangement having a load transistor and a voltage limiting circuit and method for driving a load transistor
Ion generation using wetted porous material
Electromagnetic shield for a passive electronic component in an active medical device implantable lead
Dual gate electronic memory cell and device with dual gate electronic memory cells
  Randomly Featured Patents
Chain with a single direction of curvature and application to a handrail
Vibration parts allignment apparatus
Method of and apparatus for controlling devices
Multiple methods for transacting, publishing and purchasing copyrighted digital content
Disposable potty liner
Light emitting diode lamp
Optical access system
Blood element separation apparatus
Screwdriver
Method of determining cholesterol content of high-density lipoproteins